Coronavirus information

In response to the COVID-19 global pandemic, the University of Alaska Anchorage has taken steps to protect the health and safety of our campus community. Visit the University of Alaska Coronavirus Information website to learn how UAA and the university system are responding to this situation. Find links to communications, policy guidance, resources and information about the university's community restrictions, which apply to all faculty, staff and students. The UAA Student Health and Counseling Center remains open at this time to serve UAA students. For information about COVID-19 symptoms and current health recommendations, visit the CDC website and the Alaska Department of Health and Social Services.

Seawolf Holdings, LLC

COVID-19 Research Guidance

The following technology commercialization and venture fund structure was created to commercialize technology based on faculty and student research at UAA. The UA Board of Regents approved the fund structure in July 2012. 

UAA Technology Commercialization and Private Investment Structure

The purpose of Seawolf Holdings is to: 

  • Provide a corporate interface between UAA and its enterprise companies
  • To protect the university and limit its liabilities
  • Holding and commercializing Intellectual Property
  • Manage companies and enterprises

The functions of Seawolf Holdings include:

  • Overseeing the subsidiaries
  • Identify University Intellectual property that can be commercialized and advise the fund
  • License Intellectual Property to the IP/Sub LLC
  • Review and approve all investment and divestment decisions until a 3- to 5-person investment committee is formed

The purpose of the Seawolf Venture Fund is to:

  • Provide early-stage investment in select startup companies as a for-profit private equity fund
  • Enhance the reputation of Anchorage as a center for technology advancement and innovation

Seawolf Holdings, LLC Board of Directors

Mr. Thomas Hook, CEO, Q Holding Company.

  • Former President/CEO of Integer Holdings: largest medical device outsource manufacturer in the world.
  • Led and successfully integrated acquisitions across the globe.
  • Serves on Boards of Directors of public companies.

Mr. Stephen Socolof, Managing Partner, Tech Council Ventures.

  • Founder and Managing Partner of New Venture Partners - a global venture capital firm dedicated to corporate technology spin-outs with over $700 million under management.
  • NVP Launched 50 companies built upon innovations from (Lucent, British Telecom, Boeing, GE, IBM, Intel).

Dr. John Bischoff, Managing Partner of Half Moon Ventures LLC and Adjunct Professor, George Washington University

  • Former Vice President of Finance and Operations, America Online, Inc.
  • Held executive positions at IBM, including IBM Research at Watson Labs.
  • Serves on corporate and university boards.

Mr. John Wanamaker, Managing Member, Alaska Venture Partners

  • Active angel investment practice investing in companies both in and out of Alaska.
  • Founded/co-founded 7 companies.
  • Investor/Director of the Boardroom, and Vertical Harvest Hydroponics.
  • Serves on public and private Boards of Directors.

Dr. John Sibert, Founding Chairman, National Association of Seed & Venture Funds

  • Founding Executive Director, Alaska Science &Technology Foundation.
  • Former COO Tech Transfer & Industry Collaboration, California State University Institute.
  • Member of private and public Boards of Directors.